Circulating thyrotropin receptor messenger RNA for evaluation of thyroid nodules and surveillance of thyroid cancer in children

Gutnick, Jesse; Soldes, Oliver S.; Gupta, Manjula K.; Milas, Mira

doi:10.1016/j.jpedsurg.2011.10.036

Cited by 6 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The utility of pre-operative FNAC of thyroid nodules in CYP in differentiating benign and malignant disease has been evaluated via multiple studies including one meta-analysis ( Raab et al 1995 , Khurana et al 1999 , Hosler et al 2006 , Stevens et al 2009 , Altincik et al 2010 , Bargren et al 2010 , Hoperia et al 2010 , Kapila et al 2010 , Gutnick et al 2012 , Monaco et al 2012 , Redlich et al 2012 , Cole & Wu 2014 , Rossi et al 2014 , Buryk et al 2015 , Norlen et al 2015 , Partyka et al 2016 , Trahan et al 2016 ). In CYP, pre-operative FNAC has high sensitivity and specificity, as well as high-positive predictive and negative predictive values for the diagnosis of malignancy ( Stevens et al 2009 , Moudgil et al 2016 ), although there is variability in the interpretation of cytopathology findings between institutions ( Jia et al 2021 , Vuong et al 2021 , Cherella et al 2022 ).…”

Section: Resultsmentioning

confidence: 99%

Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline

Howard

Freeston

Harrison³

et al. 2022

Endocrine-Related Cancer

View full text Add to dashboard Cite

This guideline is written as a reference document for clinicians presented with the challenge of managing paediatric patients with differentiated thyroid carcinoma up to the age of 19 years. Care of paediatric patients with differentiated thyroid carcinoma differs in key aspects from that of adults, and there have been several recent developments in the care pathways for this condition; this guideline has sought to identify and attend to these areas. It addresses the presentation, clinical assessment, diagnosis, management (both surgical and medical), genetic counselling, follow-up and prognosis of affected patients. The guideline development group formed of a multi-disciplinary panel of sub-speciality experts carried out a systematic primary literature review and Delphi consensus exercise. The guideline was developed in accordance with The Appraisal of Guidelines Research and Evaluation Instrument II criteria, with input from stakeholders including charities and patient groups. Based on scientific evidence and expert opinion, 58 recommendations have been collected to produce a clear, pragmatic set of management guidelines. It is intended as an evidence base for future optimal management and to improve the quality of clinical care of Paediatric patients with differentiated thyroid carcinoma.

show abstract

Section: Resultsmentioning

confidence: 99%

Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline

Howard

Freeston

Harrison³

et al. 2022

Endocrine-Related Cancer

View full text Add to dashboard Cite

show abstract

“…In this age group, limiting more radical thyroid surgery is always a consideration to avoid potential surgical complications related to total thyroidectomy (eg, hypocalcemia) and the need for lifelong hormone replacement therapy. Furthermore, although molecular markers are used in conjunction with FNAB quite routinely now in adults, via both researchbased and commercially available assays, the same practice has not translated to the pediatric population 41,42 largely because of the lack of evidence-based investigations of such assays in children, so that treating physicians can be reassured that they will not miss a pediatric thyroid cancer if surgery is avoided on the basis of molecular marker results. [43][44][45] Treatment of Pediatric Thyroid Malignancy In addition to being a key modality in the diagnosis of pediatric thyroid malignancy, US imaging can play an important role in guiding its treatment.…”

Section: Ogle Et Al-ultrasound In Pediatric Thyroid Malignancymentioning

confidence: 99%

Ultrasound and the Evaluation of Pediatric Thyroid Malignancy: Current Recommendations for Diagnosis and Follow‐up

Ogle

Merz

Parina

et al. 2018

J of Ultrasound Medicine

Self Cite

View full text Add to dashboard Cite

Ultrasound (US) plays a critical role in the evaluation, treatment, screening, and surveillance of thyroid malignancy in pediatric patients. This review aims to summarize recent advances in this topic. Improvements in imaging technology have amplified the advantage of US and US-guided fine-needle aspiration biopsy for thyroid nodule evaluation, cancer diagnosis, and surgical planning. Ultrasound has a definitive screening role for early cancer detection in high-risk patients, including those with a history of radiation exposure from childhood treatments, environmental radiation disasters, or hereditary/familial cancer syndromes. Finally, US is a key component of lifelong surveillance for recurrence among pediatric thyroid cancer survivors.

show abstract

Best practice for the management of pediatric thyroid cancer

Norlén

Glover

Gundara

et al. 2014

Expert Review of Endocrinology & Metabolism

View full text Add to dashboard Cite

Circulating thyrotropin receptor messenger RNA for evaluation of thyroid nodules and surveillance of thyroid cancer in children

Cited by 6 publications

References 20 publications

Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline

Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline

Ultrasound and the Evaluation of Pediatric Thyroid Malignancy: Current Recommendations for Diagnosis and Follow‐up

Best practice for the management of pediatric thyroid cancer

Contact Info

Product

Resources

About